These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 3260885)

  • 1. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
    Konturek SJ; Dembinski A; Warzecha Z; Bielanski W; Brzozowski T; Drozdowicz D
    Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats.
    Konturek SJ; Brozozowski T; Bielanski W; Warzecha Z; Drozdowicz D
    Am J Med; 1989 Jun; 86(6A):32-7. PubMed ID: 2786672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
    Konturek SJ; Radecki T; Piastucki I; Brzozowski T; Drozdowicz D
    Gut; 1987 Feb; 28(2):201-5. PubMed ID: 3470240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healing of chronic gastroduodenal ulcerations by antacids. Role of prostaglandins and epidermal growth factor.
    Konturek SJ; Brzozowski T; Drozdowicz D; Dembinski A; Nauert C
    Dig Dis Sci; 1990 Sep; 35(9):1121-9. PubMed ID: 2390927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro.
    Slomiany BL; Nishikawa H; Bilski J; Slomiany A
    Am J Gastroenterol; 1990 Apr; 85(4):390-3. PubMed ID: 2109526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Int J Tissue React; 1987; 9(5):427-32. PubMed ID: 3478321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
    Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
    Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of polyamines and prostaglandins in gastroprotective action of epidermal growth factor against ethanol injury.
    Brzozowski T; Majka J; Garlicki J; Drozdowicz D; Konturek SJ
    J Clin Gastroenterol; 1991; 13 Suppl 1():S98-102. PubMed ID: 1940205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).
    Baron JH; Barr J; Batten J; Sidebotham R; Spencer J
    Gut; 1986 May; 27(5):486-90. PubMed ID: 3084345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colloidal bismuth subcitrate in peptic ulcer--a review.
    Tytgat GN
    Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of De-Nol.
    Bader JP
    Digestion; 1987; 37 Suppl 2():53-9. PubMed ID: 3622947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Scand J Gastroenterol Suppl; 1986; 122():6-10. PubMed ID: 3465028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of growth hormone-releasing factor and somatostatin on ulcer healing and mucosal growth in rats: role of gastrin and epidermal growth factor.
    Konturek SJ; Brzozowski T; Dembinski A; Warzecha Z; Konturek PK; Yanaihara N
    Digestion; 1988; 41(3):121-8. PubMed ID: 2906300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats.
    Konturek SJ; Stachura J; Radecki T; Drozdowicz D; Brzozowski T
    Digestion; 1987; 38(2):103-13. PubMed ID: 3126091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of polyamines in gastroprotection induced by epidermal growth factor.
    Brzozowski T; Drozdowicz D; Majka J; Polonczyk-Pytko J; Konturek SJ
    J Physiol Pharmacol; 1991 Jun; 42(2):181-93. PubMed ID: 1782416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Misoprostol and de-nol in the treatment of patients with cimetidine-resistant stomach ulcer].
    Stasiewicz J; Raimer M; Kozuszyńska M; Szałaj W; Slezak L
    Pol Arch Med Wewn; 1989 Jan; 81(1):21-9. PubMed ID: 2515527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.